Standard BioTools
LAB
LAB
103 hedge funds and large institutions have $163M invested in Standard BioTools in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.95% less ownership
Funds ownership: 92% → 91.05% (-0.95%)
27% less capital invested
Capital invested by funds: $223M → $163M (-$59.8M)
Holders
103
Holding in Top 10
1
Calls
$52K
Puts
$30K
Top Buyers
| 1 | +$3.58M | |
| 2 | +$2.78M | |
| 3 | +$2.52M | |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$2.06M |
| 5 |
Millennium Management
New York
|
+$1.92M |
Top Sellers
| 1 | -$3.9M | |
| 2 | -$3.8M | |
| 3 | -$2.04M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.97M |
| 5 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
-$1.78M |